Vadodara, India

Amit Pravinbhai Sedani

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sun Pharma Advanced Research Company Limited. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amit Pravinbhai Sedani. Retrieved from https://idiyas.com/inventor/amit-pravinbhai-sedani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Amit Pravinbhai Sedani: Pioneer in Anticancer Research

Introduction: Amit Pravinbhai Sedani, based in Baroda, India, is an accomplished inventor with a significant contribution to the field of anticancer research. With two patents to his name, he is dedicated to innovating solutions that can combat cancer effectively. His work primarily focuses on novel heterocyclic compounds that serve as estrogen receptor antagonists and degraders.

Latest Patents: Amit Sedani's latest patents revolve around the development of dynamic heterocyclic antiestrogens. These novel compounds are specifically designed to act as anticancer agents, showcasing a process for their preparation. His invention underlines the critical role of estrogen receptors in cancer progression and aims to provide advanced treatment options for patients.

Career Highlights: Amit Sedani is currently associated with Sun Pharma Advanced Research Company Limited, an esteemed organization known for its commitment to pharmaceutical innovations. His tenure at the company has allowed him to contribute significantly to drug discovery and development, particularly within the oncology sector.

Collaborations: Throughout his career, Amit has had the opportunity to collaborate with notable coworkers such as Ranjan Kumar Pal and Kaushikkumar Dhanjibhai Prajapati. These collaborative efforts have fostered an environment of knowledge exchange and innovation that enhances their research capabilities.

Conclusion: Amit Pravinbhai Sedani's contributions as an inventor illustrate his dedication to advancing cancer treatment. With a focus on heterocyclic compounds and a promising career at a prominent pharmaceutical company, his innovations are poised to make a significant impact in the field of oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…